Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P. Rovers, Aeilko H. Zwinderman, Checca Bakkers et al.|BMC Cancer|2019Cited by 111
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver MetastasesMarinde J. G. Bond, Leonie J. Mekenkamp, Geert Kazemier et al.|JAMA Oncology|2024Cited by 26
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal CancerSietske C. van Nassau, Lieke H. J. Simkens, Marinde J. G. Bond et al.|JAMA Network Open|2021Cited by 10
423P From clinical trial to bedside: Triplet chemotherapy (FOLFOXIRI-B) in metastatic colorectal cancerGuus M. Bol, Miriam Koopman, Sietske C. van Nassau et al.|Annals of Oncology|2021Cited by 0